EdgarLookup

Biohaven Ltd. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Coric Vlad Chief Executive Officer Other 9,565 9,565 Oct 3, 2022
CHILDS JOHN W Other 5,000 5,000 Oct 3, 2022
Heffernan Michael Thomas Option Exercise 13,100 $2.40 $31,440 24,877 Oct 3, 2022
Gentile Kimberly SVP, Clinical Operations Option Exercise 20,716 $1.03 $21,337 116,461 Oct 3, 2022
Antonijevic Irina Other 2,535 2,535 Oct 3, 2022
Biohaven Pharmaceutical Holding Co Ltd. Other 35,839,857 35,839,857 Oct 3, 2022
Mehta Kishan Other 937 6,257 Oct 3, 2022
GREGORY JULIA P Option Exercise 9,000 $2.33 $20,970 19,117 Oct 3, 2022
CHILDS JOHN W Option Exercise 5,998 $3.56 $21,353 1,527,617 Oct 3, 2022
HUGIN ROBERT J Option Exercise 4,119 $4.84 $19,936 7,277 Oct 3, 2022
Buten Matthew Chief Financial Officer Other 18,750 21,838 Oct 3, 2022
Bailey Gregory Option Exercise 9,000 $2.33 $20,970 1,310,946 Oct 3, 2022
Coric Vlad Chief Executive Officer Option Exercise 43,750 $2.84 $124,250 696,169 Oct 3, 2022